CLINICAL_TRIALS
trial_result
· 2017-04-21
Clinical Trial Update: An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq) [Phase 4]
Summary
A Phase 4 trial investigated an alternate dosing schedule for the pentavalent rotavirus vaccine RotaTeq; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dennis Clements | Conditions: Diarrhea, Gastroenteritis | Phase 4 | Status: COMPLETED | Results posted: 2017-04-21